Comprehensive profiling of lysine lactylation in Candida albicans and exploratory analysis of fluconazole tolerance associations
Open Access
- 4 November 2025
- journal article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (11) , e0081025
Abstract
Candida albicans is the primary pathogen of invasive candidiasis in most regions worldwide, but the therapy options for C. albicans infections are limited, and drug tolerance further exacerbates the treatment challenges. Lysine lactylation (Kla), a recently identified post-translational modification (PTM), is observed in numerous organisms; however, the role of Kla in C. albicans remains unknown. Hence, we report the first proteomic analysis of this specific modification in C. albicans and discuss its potential roles in drug tolerance of C. albicans . Altogether, 7,233 lactylation sites on 1,608 lactylated proteins were identified in C. albicans , with the highest degree of lactylation among the species studied so far. The further bioinformatics analysis revealed that the lactylated proteins were implicated in a variety of cellular functions with diverse subcellular localizations. Additionally, we found a unique survival mode of tolerant cells in the presence of fluconazole, which will be subject to a more thorough investigation in our future studies. This paper is the first report on the lactylome of Candida spp. and provides a reliable foundation for further research on Kla in C. albicans and other human pathogens. IMPORTANCE: This is the first report on the lactylome of Candida spp., and it provides some valuable insights for further research on lactylation in C. albicans and other human pathogens. Moreover, the observations in tolerant cells have prompted plausible hypotheses regarding the potential role of lactylation in mediating C. albicans tolerance to fluconazole, thereby offering a conceptual framework for subsequent investigations. Notably, fungal tolerance to azoles, a concept distinct from resistance, represents a critical phenomenon in C. albicans with profound clinical implications, as it directly correlates with therapeutic failure and persistent infections.Keywords
This publication has 62 references indexed in Scilit:
- Protocols for Measuring Tolerant and Heteroresistant Drug Responses of Pathogenic Yeasts2023
- Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinomaProteomics, 2023
- Lactylation: a Passing Fad or the Future of Posttranslational ModificationInflammation, 2022
- Invasive candidiasis in critical care: challenges and future directionsIntensive Care Medicine, 2020
- Histone Modifications: Insights into Their Influence on Gene ExpressionCell, 2018
- JMJD3 as an epigenetic regulator in development and diseaseThe International Journal of Biochemistry & Cell Biology, 2015
- Candida albicans ENO1 null mutants exhibit altered drug susceptibility, hyphal formation, and virulenceJournal of Microbiology, 2013
- Lysine Deacetylases Hda1 and Rpd3 Regulate Hsp90 Function thereby Governing Fungal Drug ResistanceCell Reports, 2012
- Cancer Epigenetics: From Mechanism to TherapyCell, 2012
- Scp160p, a new yeast protein associated with the nuclear membrane and the endoplasmic reticulum, is necessary for maintenance of exact ploidyYeast, 1995